- Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution
-
Watari S, Ichikawa T, Shiraishi H, Tokunaga M, Kubota R, Kusumi N, Tsushima T
- KMID: 2540064
- Investig Clin Urol.
- 2023 Mar;64(2):168-174.
- doi: 10.4111/icu.20220380
Purpose: The usefulness of the urine loss ratio in the early postoperative period for prognosis of long-term urinary continence after radical prostatectomy has not been fully determined. Materials and Methods: All... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume
-
Tsuboi I, Maruyama Y, Sadahira T, Ando N, Nishiyama Y, Araki M, Kurashige T, Ichikawa T, Arata R, Ono N, Watanabe T, Hayata S, Shiina H, Nasu Y
- KMID: 2515323
- Investig Clin Urol.
- 2021 May;62(3):298-304.
- doi: 10.4111/icu.20200450
Purpose: To evaluate the efficacy of holmium laser enucleation of the prostate (HoLEP) in patients with a small prostate volume (≤30 mL). Materials and Methods: We retrospectively evaluated 1,135 patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy
-
Sazuka T, Nihei N, Nakamura K, Sakamoto S, Fukasawa S, Komaru A, Ueda T, Igarashi T, Ichikawa T
- KMID: 2133288
- Korean J Urol.
- 2015 Mar;56(3):205-211.
- doi: 10.4111/kju.2015.56.3.205
PURPOSE: Single-agent interferon (IFN) is no longer regarded as a standard option for first-line systemic treatment of metastatic renal cell carcinoma (RCC) in Western countries. However, some patients with favorable-risk... -
- CITED
-
- Close
- SHARE
-
- Close
